February 10, 2023
DNAstack named Company of the Year by Life Sciences Ontario
Award recognizes Toronto company’s global impact on genomics and health research.
Award recognizes Toronto company’s global impact on genomics and health research.
DNAstack drives medical breakthroughs with its federated data discovery and analysis platform built on open standards. The company was selected for establishing federated data networks and powering insights in pandemic surveillance, neuroscience, rare disease, and oncology.
Harnessing artificial intelligence to take the guesswork out of diagnosing cancer recurrence for millions of cancer survivors
DNAstack today announced Viral AI, a federated network for genomic variant surveillance and infectious disease research. Viral AI was designed to deliver equitable access to software infrastructure, accelerate international data sharing, and empower scientists and public health officials with globally representative datasets they need to mitigate current and future infectious disease outbreaks.
Our world is constantly changing and at its core, innovation is really about responding to change in a new, creative way. It requires courage, conviction, resilience, the support of a community of collaborators, and innovation-oriented policies in order to succeed.Read More
To combat the current COVID-19 pandemic, scientists around the world are sequencing viral genomes at an accelerated pace.
DNAstack’s bioinformatician Heather Ward breaks down the biology of the novel coronavirus responsible for the COVID-19 outbreak.
Despite advances in sequencing and analysis tools, calling variants in whole-genome sequencing (WGS) data is not trivial, even when dealing with only a few dozen samples.
We fundamentally believe that democratization of genomics information through sharing will massively accelerate discoveries that will lead to better treatments and outcomes for patients affected by genetic diseases.